[LRMR] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -73,980.00%
YoY- 76.52%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -8,667 -12,609 -11,330 -3,704 -15,775 -13,347 -15,028 -8.76%
Tax -20 0 -32 -8,482 0 0 0 -
NP -8,647 -12,609 -11,330 -3,704 -15,775 -13,347 -15,028 -8.79%
Tax Rate - - - - - - - -
Total Cost 8,647 12,609 11,330 3,704 15,775 13,347 15,028 -8.79%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.47 -0.79 -1.21 -0.40 -5.72 -4.87 -5.51 -33.64%
EPS Diluted -0.47 -0.79 -1.21 -0.40 -5.72 -4.87 -5.51 -33.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.